Angiostatic steroids and methods and compositions for controlling ocular hypertension
US5371078A · kind A · utility
77Cited by
3References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 8, 1992 |
| Grant date | Dec 6, 1994 |
| Priority date | — |
| Expiry date | Sep 8, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J51/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Angiostatic steroids for use in controlling ocular hypertension are disclosed. Pharmaceutical compositions of the angiostatic steroids and methods for their use in treating ocular hypertension, including controlling the ocular hypertension associated with primary open angle glaucoma, are disclosed. In addition, the combination of the compounds with glucocorticoids for the prevention of elevated IOP during the treatment of inflammation is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.